Recent Publications

Impact of Bimekizumab and Certolizumab Pegol on Efficacy, Safety and Osteoblastic Activity in Radiographic Axial Spondyloarthritis: Results from a Phase IIa, Multicentre, Randomised, Double-Blind, Exploratory Study with PET-CT Imaging

Nutrition Reviews, nuae150, October 2024
Authors: Xenofon Baraliakos, Jerney de Jongh, Denis Poddubnyy, Gerben J. C. Zwezerijnen, Robert Hemke, Sophie Glatt, Stevan Shaw, Lucian Ionescu, Assem el Baghdady, Joanne Mann, Ralph Paul Maguire, Tom Vaux, Natasha de Peyrecave, Marga Oortgiesen, Dominique Baeten, and Conny van der Laken

Living With Multiple Sclerosis: The South Asian Experience

British Journal of Neuroscience Nursing, Vol. 20, No. Sup4, September 2024
Author: Trishna Bharadia

Understanding Global Access to Topical Onychomycosis Therapy: A Systematic Review and Meta-Analysis

Mycoses, Volume 67, Issue 9, September 2024
Authors: S. M. Nasereddin, J. L. Li, O. S. Malallah, G. R. McClelland, D. Morgan, S. Meadowcroft, A. Bolhuis, S. A. Jones

Mimicking Sun Exposure With a Novel Transdermal Vitamin D Supplement: A Focus on Local Keratinocyte and Systemic Production of the Vitamin D Binding Protein

Current Developments in Nutrition, Volume 8, 103759, July 2024
Authors: Stuart A Jones, Charlie Lim, Peter Luebcke, Mohamed Alhnan

Blended e-learning and certification for medicines development professionals: results of a 7-year collaboration between King’s College, London and the GMDP Academy, New York

Frontiers in Pharmacology, Volume 15, June 2024
Authors: Honorio Silva, Peter Stonier, Pravin Chopra, Jacob Coots, Domenico Criscuolo, Soneil Guptha, Stuart Jones, Sandor Kerpel-Fronius, Gustavo Kesselring, Xavier Luria, David Morgan, Eddie Power, Sam Salek, Gustavo Silva, Tamas Suto, Kamlesh Thakker, Pol Vandenbroucke

Patient & Public Involvement – Stranded on the Adoption Curve?

DIA Global Forum, April 2024
Authors: Liz Clark, Amy Rogers

Reshaping consent so we might improve participant choice (III) – How is the research participant’s understanding currently checked and how might we improve this process?

Research Ethics, Volume 20, Issue 3, February 2024
Authors: Hugh Davies, Simon E Kolstoe and Anthony Lockett

Systematic review and QSPR analysis of chemical penetration through the nail to inform onychomycosis candidate selection

Drug Discovery Today, Volume 29, Issue 1, January 2024, 103844. Authors: Osamah S. Malallah, Lucy Coleman, Sara M. Nasereddin, Mohammad Lockhat, Tao Chen, Stuart A. Jones

Previous Publications

Ensovibep, a SARS-CoV-2 antiviral designed ankyrin repeat protein, is safe and well tolerated in healthy volunteers: Results of a first-in-human, ascending single-dose Phase 1 study

British British Journal of Clinical Pharmacology, Volume 89, Issue 7: Page 1911, July 2023
Authors: Nina Stojcheva, Stacy Gladman, Marianne Soergel, Christof Zitt, Roxana Drake, Tony Lockett, Carine Marchand, Pierre Fustier, Vaia Stavropoulou, Elena Fernandez, Nathana Lopes Pettigiani, Kate Watkins, Adeep Puri, Randall Watson, Philippe Legenne, Michael T. Stumpp, Malcolm Boyce

The use of near-infrared as process analytical technology (PAT) during 3D printing tablets at the point-of-care

International Journal of Pharmaceutics, Volume 642, July 2023
Authors: Tzuyi L. Yang, Jakub Szewc, Lingu Zhong, Anna Leonova, Joanna Giebułtowicz, Rober Habashy, Abdullah Isreb, Mohamed A. Alhnan

Towards point-of-care manufacturing and analysis of immediate-release 3D-printed hydrocortisone tablets for the treatment of congenital adrenal hyperplasia

International Journal of Pharmaceutics, Volume 642, July 2023
Authors: Tzuyi L. Yang, Melpomeni Stogiannari, Sylwia Janeczko, Marva Khoshan, Yueyuan Lin, Abdullah Isreb, Rober Habashy, Joanna Giebułtowicz, Matthew Peak, Mohamed A. Alhnan

Advancing patient-centricity in Medical Affairs: A survey of patients and patient organizations

Drug Discovery Today, Volume 28, Issue 7, July 2023
Authors: Dahlia Amin, Pol Vandenbroucke

A systematic review of models of patient engagement in the development and lifecycle management of medicines

Drug Discovery Today, Volume 28, Issue 9
Authors: F.I. Auwal, C. Copeland, E.J. Clark, C. Naraynassamy, G.R. McClelland

Responsible impact and the reinforcement of responsible innovation in the public sector ecosystem: cases of digital health innovation

Journal of Responsible Innovation, Volume 10, Issue 1, May 2023
Authors: Bernard Naughton, Sue Dopson, Tatiana Iakovleva

Professional Competencies and Capabilities in the Development of Medicines

Pharmaceutical Magazine, February 2025
Authors: Peter D. Stonier & Stuart A. Jones

Systematic Review of Pre-Clinical Systems Using Artificial Microenvironments and Anti-Migratory Drugs to Control Migration of Glioblastoma Cells

Cambridge University Press, Expert Reviews in Molecular Medicine, Volume 27, e6, January 2025
Authors: Hana Selvi, Anke Brüning-Richardson, Davide Danovi

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the Neonatal Fc Receptor Inhibitor Rozanolixizumab: An Ethnic Sensitivity Study in Healthy Japanese, Chinese, and White Participants

Clinical Pharmacology in Drug Development, Volume 14, Issue 1, January 2025
Authors: Assem el Baghdady, Rocío Lledó-García, Maryam Gayfieva, Romana Lowcock, Shikiko Watanabe, Jagdev Sidhu, Denisa Wilkes

Has The UK Lost Its Position As A Destination For World-Leading Clinical Research? A comparative Analysis of Haematological Cancer Clinical Trials Performance Before Brexit

BMJ Open, December 2024
Authors: Meena Arora, Adrian Kilcoyne, John Bolodeoku, Assem el Baghdady

Ethnic Differences in Response to Oral Vitamin D Supplementation: A Systematic Review and Meta-Analysis

Therapeutic Advances in Musculoskeletal Disease, Volume 16, October 2024
Authors: Sumayah Abdul-jabbar , Chukwuebuka Nebechi , Graham R McClelland , Anthony Lockett , Abdel Douiri , David Morgan , Stuart A Jones

The Central Role of Ethics in Medical Affairs Practice

Pharmaceutical Medicine 37, Page 275, May 2023
Author: Carl Naraynassamy

The missing piece of the Windsor Framework: the patients

BMJ, Issue 361, Page 961, May 2023
Author: Francesca Mason

Quizartinib plus chemotherapy in newly diagnosed patients with FLT3-internal-tandem-duplication-positive acute myeloid leukaemia (QuANTUM-First): a randomised, double-blind, placebo-controlled, phase 3 trial

The Lancet, Volume 401, Issue 10388, Page 1571, April 2023
Authors: Harry P Erba, Pau Montesinos, Hee-Je Kim, Elżbieta Patkowska, Radovan Vrhovac, Pavel Žák, Po-Nan Wang, Tsvetomir Mitov, James Hanyok, Yasser Mostafa Kamel, Jaime E Connolly Rohrbach, Li Liu, Aziz Benzohra, Arnaud Lesegretain, Jorge Cortes, Alexander E Perl, Mikkael A Sekeres, Hervé Dombret, Sergio Amadori, Jianxiang Wang, Mark J Levis, Richard F Schlenk

A case-control study of antipsychotic use and pneumonia-related mortality in the United Kingdom

Acta Psychiatrica Scandinavica, Volume 147, Issue 3, Page 229, Mar 2023
Authors: Caroline S Copeland, Phoebe Wallman, David Morgan, Eleanor Owen, David Taylor

Serum amyloid A—A potential therapeutic target for hyper-inflammatory syndrome associated with COVID-19

Frontiers in Medicine, Volume 10, March 2023
Authors: Eman M. Almusalami, Anthony Lockett, Albert Ferro1, John Posner

The use of Special-Order products in England between 2012 and 2020: An insight into the need for Point-of-Care manufacturing

International Journal of Pharmaceutics, Volume 637, February 2023
Authors: Alan Phillips, Shalini Mondal

Improving early phase oncology clinical trial design: The case for finding the optimal biological dose

Pharmaceutical Statistics, Volume 22, Issue 4, July 2023
Authors: Anna O'Donovan, Jennifer C Duncan, Kuan-Yin Li, Lucy Del-Nevo, Andrea Gill, Matthew Peak, Mohamed A Alhnan

CAR-T: What Is Next?

Cancers, Issue 15, Volume 3, Page 663, January 2023
Authors: Chen, Yi-Ju, Bams Abila, Yasser Mostafa Kamel